BioTech EOCN

Galemed's First-in-Human Study Validated Colospan Tissue Tech; Stock Up

(RTTNews) - Galemed Pharmaceuticals Ltd. (GLMD) through its wholly owned subsidiary Colospan Ltd., announced positive proof-of-concept results from a first-in-human feasibility study of its novel intraoperative tissue assessment technology.

The prospective, single-arm study enrolled 32 colorectal cancer patients undergoing elective surgery at three leading medical centers in Israel. The primary objective was to demonstrate the feasibility of quantitatively measuring colon tissue quality during surgery.

Results showed successful measurements in all patients, with no technical failures or procedure-related issues, establishing a strong clinical foundation for further development.

The new platform complements Colospan's CG-100 intraluminal bypass device and expands Galmed's innovation pipeline in colorectal surgery. By providing surgeons with real-time, objective data on tissue mechanical properties, the technology aims to support intraoperative decision-making, improve surgical planning, and potentially help identify patients at risk of complications such as Low Anterior Resection Syndrome (LARS).

Allen Baharaff, President and CEO of Galmed Pharmaceuticals, stated that the successful study results reinforce Galmed's strategy to build a diversified portfolio of medtech and biotech solutions addressing unmet needs in gastrointestinal oncology and colorectal surgery.

The company announced it will implement a 1-for-8 reverse stock split today on August 19, 2026.

GLMD has traded between $3.28 and $13.20 over the past year. The stock is currently trading at $5.31, up 18.46%

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available